We are live on ! Find out more
AUGX

Augmedix, Inc. Common Stock

Delisted

AUGX was delisted on the 1st of October, 2024.

84 hedge funds and large institutions have $162M invested in Augmedix, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

7% more call options, than puts

Call options by funds: $2.21M | Put options by funds: $2.07M

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

1% less funds holding

Funds holding: 8584 (-1)

23% less capital invested

Capital invested by funds: $209M → $162M (-$47.4M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
84
Holders Change
-1
Holders Change %
-1.18%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
37
Reduced
18
Closed
19
Calls
$2.21M
Puts
$2.07M
Net Calls
+$142K
Net Calls Change
-$447K
Name Holding Trade Value Shares
Change
Change in
Stake
RG
1
Redmile Group
California
$67M
SM
2
Samjo Management
New York
$16.2M +$4.48M +1,002,200 +34%
Citadel Advisors
3
Citadel Advisors
Florida
$7.73M +$8.13M +1,817,233 +2,529%
PCM
4
Perkins Capital Management
Minnesota
$5.96M -$28.2K -6,300 -0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.33M +$803K +179,534 +16%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$4.83M +$3.06M +682,924 +137%
PHP
7
Parkman Healthcare Partners
Connecticut
$4.36M +$225K +50,295 +5%
Millennium Management
8
Millennium Management
New York
$4.27M +$2.9M +649,054 +164%
RPAM
9
Rhenman & Partners Asset Management
Sweden
$3.27M +$3.58M +800,000 New
Russell Investments Group
10
Russell Investments Group
United Kingdom
$2.69M -$1.05M -234,031 -26%
GIPM
11
G2 Investment Partners Management
New York
$2.57M +$129K +28,886 +5%
EIM
12
Essex Investment Management
Massachusetts
$2.16M +$561K +125,457 +31%
AAP
13
Ardsley Advisory Partners
Connecticut
$2.15M
AFG
14
American Financial Group
Ohio
$2.04M
HRCM
15
Hood River Capital Management
Florida
$2.01M +$968K +216,339 +79%
SSA
16
Schonfeld Strategic Advisors
New York
$1.92M +$922K +206,173 +78%
AA
17
Ancora Advisors
Ohio
$1.82M +$1.01M +225,330 +103%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.76M +$309K +69,150 +19%
KCM
19
Kennedy Capital Management
Missouri
$1.52M -$128K -28,564 -7%
NCGI
20
Next Century Growth Investors
Minnesota
$1.48M +$7.53K +1,683 +0.5%
Marshall Wace
21
Marshall Wace
United Kingdom
$1.38M +$1.32M +294,720 +674%
MAG
22
Millrace Asset Group
Pennsylvania
$1.22M +$425K +95,060 +47%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$1.08M +$453K +101,322 +63%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$908K +$540K +120,729 +119%
LCM
25
Legato Capital Management
California
$856K +$207K +46,226 +28%

AUGX Hedge Fund Activity: Q1 2024 in Review

84 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q1 2024, worth a combined $162M — down 23% from $209M a quarter earlier.

Fund positioning in AUGX was balanced in Q1 2024: 19 funds opened new positions, 19 closed out, 37 added to existing stakes and 18 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $8.13M. The largest seller was Divisadero Street Capital Management, cutting an estimated $7.55M.

  • 84 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q1 2024, down from 85 in Q4 2023.
  • Funds reported $162M of Augmedix, Inc. Common Stock stock for Q1 2024, down 23% quarter-over-quarter.
  • 19 funds opened new Augmedix, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of 0 holders.
  • The largest Augmedix, Inc. Common Stock buyer in Q1 2024 was Citadel Advisors, an estimated $8.13M added.
  • The largest Augmedix, Inc. Common Stock seller in Q1 2024 was Divisadero Street Capital Management, an estimated $7.55M sold.

Based on aggregated 13F filings for Q1 2024.